Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3869 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

EU approves opioid misuse drug

Suboxone is intended for use in adults and adolescents 15 years of age and older who have agreed to be treated for addiction. Suboxone is currently the only

Tumor suppressor gene may stimulate tumor growth

Tumor suppressor genes function by regulating normal cell growth and proliferation. When a tumor suppressor gene is turned off, by mutation, deletion, or blocked expression, cell growth can

Breakthrough in treatment for MDS patients

The study, from the H Lee Moffitt Cancer Center & Research Institute and sponsored by Celgene, evaluated response in 148 patients. The data published found that more than

Eurand to develop new product for GSK

Eurand's Microcaps technology, which will be used in the process, is a precise coating technique used to encapsulate individual drug particles which can mask taste and provide sustained

FDA backs Vytorin treatment claim

The new data was from a study of patients with high cholesterol that showed Vytorin, along with diet, lowered LDL “bad” cholesterol more than Crestor. This response was

Biotica enters license agreement with Wyeth

Biotica has granted Wyeth worldwide rights to its most advanced drug candidates, a portfolio of additional rapamycin analogs, and the technology to discover new compounds. The companies will

FDA fast track for Agennix drug

Fast track is a process designed to facilitate the development and expedite the review of drugs that treat serious diseases and address unmet medical needs. Agennix submitted applications